MIB:PA:PA-Lyxor FTSE MIB (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 33.62

Change

-0.50 (-1.47)%

Market Cap

USD 0.43B

Volume

340.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.31 (+0.66%)

USD 64.41B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.40 (-0.08%)

USD 12.63B
WRD:PA HSBC ETFs Public Limited Compa..

-0.10 (-0.30%)

USD 10.26B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-2.10 (-0.86%)

USD 8.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 7.98B
HHH:PA HSBC ETFs Public Limited Compa..

-0.05 (-0.09%)

USD 7.03B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.75 (-0.22%)

USD 6.87B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.06 (-0.35%)

USD 6.47B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

N/A

USD 5.17B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.30 (+0.20%)

USD 4.78B

ETFs Containing MIB:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.47% 65% D 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.47% 66% D+ 72% C
Trailing 12 Months  
Capital Gain 21.68% 54% F 69% C-
Dividend Return 4.05% 58% F 68% D+
Total Return 25.73% 65% D 74% C
Trailing 5 Years  
Capital Gain 61.99% 70% C- 77% C+
Dividend Return 14.07% 75% C 58% F
Total Return 76.05% 77% C+ 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 14.22% N/A N/A 75% C
Dividend Return 16.90% N/A N/A 79% B-
Total Return 2.68% N/A N/A 64% D
Risk Return Profile  
Volatility (Standard Deviation) 18.79% N/A N/A 55% F
Risk Adjusted Return 89.92% N/A N/A 92% A
Market Capitalization 0.43B 62% D 67% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike